Article

Evaluation of Low Coverage Whole Genome Sequencing as a New Method for Detecting Malignant Ovarian Mass

2021-06-07

Abstract excerpt

<title>Abstract</title> <p>To evaluate whether low coverage whole genome sequencing is suitable for the detection of malignant pelvic mass and compare its diagnostic value with traditional tumor markers. We enrolled 63 patients with a pelvic mass suspicious for ovarian malignancy. Each patient underwent low coverage whole genome sequencing (LCWGS) and traditional tumor markers test. The pelvic masses were finally...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fe0edf65-b1ef-5605-9242-37bad7912b28
DOI: 10.21203/rs.3.rs-535366/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluation of Low Coverage Whole Genome Sequencing as a New Method for Detecting Malignant Ovarian MassDOI 10.21203/rs.3.rs-535366/v1Read

Detection and characterization of copy number variants based on whole-genome sequencing by DNBSEQ platformsSemantic proximity Read

Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patientsSemantic proximity Read

Genomic Copy Number Variation Profiling of Pleural Effusion cfDNA via LP-WGS for Precision Diagnosis and Prognostic Stratification in Lung Adenocarcinoma-associated Malignant Pleural Effusion running title: cfDNA CNV for LUAD-MPE Diagnosis and PrognosisSemantic proximity Read

Whole-exome sequencing reveals potential germline and somatic mutations in 60 malignant ovarian germ cell tumors†.Semantic proximity Read

Untitled literature recordSemantic proximity Read

Low-Coverage Whole Genome Sequencing Diagnoses Endometrial Carcinoma from Tampon DNA of Uterine Bleeding PatientsSemantic proximity Read

Characterizing sensitivity and coverage of clinical WGS as a diagnostic test for genetic disordersSemantic proximity Read

Molecular analysis for ovarian cancer detection in patient-friendly samplesSemantic proximity Read

The circulating miRNA-34a, miRNA -143 and miRNA -212 are promising biomarkers in ovarian cancerSemantic proximity Read

Low-coverage genome sequencing for the detection of clinically relevant copy-number and mtDNA variantsSemantic proximity Read

Integrative analysis of cfDNA features from ultra-low coverage whole genome sequencing enables robust detection of ovarian cancerSemantic proximity Read

A Single Cell Level Based Method for Copy Number Variation Analysis by Low Coverage Massively Parallel SequencingSemantic proximity Read